Mark Viljoen
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
- HIV, Drug Use, Sexual Risk
- Substance Abuse Treatment and Outcomes
Papers in
-
- Liver Disease Diagnosis and Treatment 4
- Hepatitis B Virus Studies 3
- HIV, Drug Use, Sexual Risk 1
-
- HIV/AIDS Research and Interventions 4
- HIV/AIDS drug development and treatment 3
- Co-authors
- Jason Grebely (8 shared papers)Fiona Duncan (6 shared papers)Jesse D. Raffa (7 shared papers)Brian Conway (7 shared papers)Milan Khara (7 shared papers)Stanley DeVlaming (7 shared papers)Krista Genoway (3 shared papers)Doug Elliott (2 shared papers)
- Journals
- JAIDS Journal of Acquired Immune Deficiency Syndromes (1 paper)Journal of Addictive Diseases (1 paper)International Journal of Infectious Diseases (1 paper)European Journal of Gastroenterology & Hepatology (1 paper)Drug and Alcohol Dependence (1 paper)
- Partner nations
- CanadaAustraliaUnited States
In The Last Decade
Mark Viljoen
8 papers receiving 340 citations
Peers
Comparison fields: 5 of 38
- Hepatology 273
- Epidemiology 312
- Infectious Diseases 87
- Virology 17
- Family Practice 5
Countries citing papers authored by Mark Viljoen
This map shows the geographic impact of Mark Viljoen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Viljoen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Viljoen more than expected).
Fields of papers citing papers by Mark Viljoen
This network shows the impact of papers produced by Mark Viljoen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Viljoen. The network helps show where Mark Viljoen may publish in the future.
Co-authors
The 15 scholars most cited alongside Mark Viljoen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 103 | |
| 2 | 2007 | 87 | |
| 3 | 2007 | 65 | |
| 4 | 2007 | 53 | |
| 5 | 2008 | 29 | |
| 6 | 2007 | 11 | |
| 7 | 2008 | 7 | |
| 8 | 2007 | 2 |
About Mark Viljoen
Mark Viljoen is a scholar working on Epidemiology, Infectious Diseases, Hepatology, Virology and Pathology and Forensic Medicine, having authored 8 papers that have together received 357 indexed citations. Recurring topics across this work include Hepatitis C virus research (4 papers), HIV/AIDS Research and Interventions (4 papers), Liver Disease Diagnosis and Treatment (4 papers), HIV Research and Treatment (3 papers), Hepatitis B Virus Studies (3 papers), HIV/AIDS drug development and treatment (3 papers), Alcohol Consumption and Health Effects (1 paper) and HIV, Drug Use, Sexual Risk (1 paper). The work is most often cited by research in Hepatology (273 citations), Epidemiology (312 citations), Infectious Diseases (87 citations), Virology (17 citations) and Family Practice (5 citations). Mark Viljoen has collaborated with scholars based in Canada, Australia and United States. Frequent co-authors include Jason Grebely, Fiona Duncan, Jesse D. Raffa, Brian Conway, Milan Khara, Stanley DeVlaming, Krista Genoway, Doug Elliott, Annabel Mead and Mark McLean. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, Journal of Addictive Diseases, International Journal of Infectious Diseases, European Journal of Gastroenterology & Hepatology and Drug and Alcohol Dependence.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.